Cargando…

SARS-CoV-2 (COVID-19) in the history of the pandemics: a tsunami that is changing the world

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore srl 2021
Materias:	SARS-CoV-2 (COVID-19) in the history of the pandemics: a tsunami that is changing the world
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452287/ https://www.ncbi.nlm.nih.gov/pubmed/34622077 http://dx.doi.org/10.15167/2421-4248/jpmh2021.62.1S3

Ejemplares similares

Tsunami = Next wave: science of tsunami /
Publicado: (2005)

Thrombose und COVID-19
por: Tzaneva, Stanislava
Publicado: (2021)

Protective neutralizing epitopes in SARS‐CoV‐2
por: Liu, Hejun, et al.
Publicado: (2022)

Effect of farnesyltransferase inhibitors on SARS-CoV-2
por: Weber, Lea, et al.
Publicado: (2023)

Clinical evaluation of SARS-CoV-2 point-of-care antibody tests
por: Robosa, Roselle S., et al.
Publicado: (2020)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings
por: Chong, Brian S.W., et al.
Publicado: (2020)

Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
por: Chua, Kyra Y.L., et al.
Publicado: (2020)

Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes
por: Stelzer-Braid, Sacha, et al.
Publicado: (2020)

Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent
por: Kaufer, Alexa M., et al.
Publicado: (2020)

In vitro evaluation of the virucidal activity of disodium citrate perhydrate (2SCP) disinfectant against SARS-CoV-2
por: Dessilly, Géraldine, et al.
Publicado: (2022)

LBA8 Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
por: Oosting, S., et al.
Publicado: (2021)

An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study
por: Laino, Maria Elena, et al.
Publicado: (2022)

LBA69 Impact of the COVID-19 pandemic on management of medical cancer treatments and psychological consequence for the patients
por: Joly, F., et al.
Publicado: (2020)

What prompts clinicians to start antibiotic treatment in COVID-19 patients? An Italian web survey helps us to understand where the doubts lie
por: Colaneri, Marta, et al.
Publicado: (2021)

Back to the future (of common respiratory viruses)
por: Mattana, Giordana, et al.
Publicado: (2022)

Ventilation support in SARS-CoV-2 pneumonia. Strategy and indications
por: Gordo, Federico, et al.
Publicado: (2022)

Characteristics of SARS-CoV-2 Delta variant-infected individuals with intermittently positive retest viral RNA after discharge
por: Li, Lu, et al.
Publicado: (2022)

Vaccination strategies against SARS-CoV-2: General impact on the development of the pandemic
por: de Miguel, Ángel Gil, et al.
Publicado: (2021)

Neutralizing antibodies for SARS-CoV-2 infection
por: Berenguer, Juan
Publicado: (2022)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

Ventilatory support and corticosteroid therapy in SARS-CoV-2
por: Sagasti, Fernando Martínez, et al.
Publicado: (2021)

Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
por: Hall, Matthew D, et al.
Publicado: (2021)

Vulnerability to SARS-CoV-2 infection and disease: ripping the curl after the storm
por: Barreiro, Pablo, et al.
Publicado: (2022)

Role of molecular diagnostics in the clinical management of SARS-CoV-2 infection: advantages and drawbacks
por: Martín-Higuera, Carmen, et al.
Publicado: (2021)

Comprehensive serological strategy for the diagnosis and monitoring of SARS-CoV-2. From infection to vaccine control
por: Delgado, Rafael
Publicado: (2021)

Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury
por: Liu, Yingxia, et al.
Publicado: (2020)

Plasma metabolomic and lipidomic alterations associated with COVID-19
por: Wu, Di, et al.
Publicado: (2020)

Respiratory consequences after COVID-19: outcome and treatment
por: Molina-Molina, María, et al.
Publicado: (2022)

Immune treatment in COVID-19
por: Menéndez, Rosario, et al.
Publicado: (2022)

Steroid therapy and antiviral treatment in SARSCoV-2 pneumonia: clinical contexts and indications
por: Torres, Antoni, et al.
Publicado: (2022)

Respiratory infections in Coronavirus disease 2019
por: del Pozo, Jose L.
Publicado: (2022)

Lineage-specific positive selection on ACE2 contributes to the genetic susceptibility of COVID-19
por: Pan, Yuwen, et al.
Publicado: (2022)

Open Science and its role during the COVID-19 pandemic
por: Díaz Fragoso, Omar, et al.
Publicado: (2021)

SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
por: Williams, Phoebe C.M., et al.
Publicado: (2020)

Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays
por: Tan, Shaun S., et al.
Publicado: (2020)

Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort
por: Davidson, N., et al.
Publicado: (2020)

Approach to COVID-19 pandemic management in Madrid. Chronic of a year
por: Candel, Francisco Javier, et al.
Publicado: (2021)

An overview of SARS-COV-2-related hepatic injury
por: Tarik Aslan, Abdullah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_epon79ts4iij2hus5gl6pegkuv